Transaction #7146 · Form 4 · 0001214659-25-016275
Aquestive Therapeutics, Inc. · Stock award · Non-Qualified Stock Option (right to buy)
Aquestive Therapeutics, Inc. · Transacted November 10, 2025 · Filed November 12, 2025
What does this filing report?
An SEC Form 4 filing for Aquestive Therapeutics, Inc. records a stock award involving Non-Qualified Stock Option (right to buy) on November 10, 2025. The reported quantity was 50,000. The filing date is November 12, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Aquestive Therapeutics, Inc.
- Company CIK
- 0001398733
- Security type
- Derivative
- Acquisition type
- Stock award · Code A
- Quantity acquired
- 50,000
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 50,000
- Ownership description
- Not reported
- SEC acceptance time
- Nov 12, 2025, 9:35 AM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Davis Matthew W. ↗
Chief Development Officer
CIK 0002094283
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 50,000
- Conversion / exercise price
- 5.58
- Exercise date
- Not reported
- Expiration date
- November 10, 2035
Filing footnotes & remarks
- F1
- The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.
- F2
- The option will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.